Ekso Bionics Holdings

Rising Healthcare Spending And Aging Populations Will Expand Rehab Robotics

AnalystHighTarget

Not Invested

Consensus Narrative from 2 Analysts

Published

25 Aug 25

Updated

25 Aug 25

AnalystHighTarget's Fair Value

US$9.50

60.6% undervalued

25 Aug

US$3.74

-77.9%

20.6%

-77.9%

20.6%

Author's Valuation

US$9.5

60.6% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$9.5

60.6% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

20.44%

Medical Equipment revenue growth rate

0.45%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.71%

Calculation

US$6.36m

Earnings '28

11.03x

PE Ratio '28

US$70.17m

Market Cap '28

US$70.17m

Market Cap '28

5.74m

No. shares '28

US$12.23

Share Price '28

US$12.23 Share Price '28

Discounted to 2025 @ 8.78% p.a.

US$9.50

Fair Value '25